Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Jan 11, 2017	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-17-001860.pdf 0001144204-17-001860.rtf 0001144204-17-001860.xls
Jan 11, 2017	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-17-001859.pdf 0001144204-17-001859.rtf 0001144204-17-001859.xls
Jan 11, 2017	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-17-001862.pdf 0001144204-17-001862.rtf 0001144204-17-001862.xls
Jan 6, 2017	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-17-000004.pdf 0000320017-17-000004.rtf 0000320017-17-000004.xls
Jan 6, 2017	S-8	Securities offered to employees pursuant to employee benefit plans	View HTML 0000320017-17-000002.pdf 0000320017-17-000002.rtf 0000320017-17-000002.xls
Dec 30, 2016	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-16-000171.pdf 0000320017-16-000171.rtf 0000320017-16-000171.xls
Dec 19, 2016	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0000320017-16-000169.pdf 0000320017-16-000169.rtf 0000320017-16-000169.xls
Dec 19, 2016	EFFECT	EFFECT	View HTML 9999999995-16-006494.pdf 9999999995-16-006494.rtf 9999999995-16-006494.xls
Dec 16, 2016	CORRESP	CORRESP	View HTML 0001144204-16-140063.pdf 0001144204-16-140063.rtf 0001144204-16-140063.xls
Nov 30, 2016	UPLOAD	UPLOAD	View HTML 0000000000-16-102866.pdf